Last updated on February 2018

Post-Marketing Study Using PROLIEVE for the Treatment of Benign Prostatic Hyperplasia (BPH)


Brief description of study

The primary objective of the post-marketing study is to collect safety and effectiveness data for 5 years on subjects treated with Prolieve. The collection of 5-year safety information will be used to evaluate the occurrence of any long-term side effects from the treatment. The collection of long-term effectiveness data on subjects treated with Prolieve will provide information on the long-term effects of treatment and time to re- treatment (any treatment initiated for BPH since Prolieve'" treatment, including a second treatment with Prolieve").

Clinical Study Identifier: NCT02021032

Contact Investigators or Research Sites near you

Start Over

Regional Urology

Shreveport, LA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.